X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (254) 254
index medicus (169) 169
virology (159) 159
viruses (117) 117
hiv-1 - genetics (116) 116
hiv (115) 115
env gene products, human immunodeficiency virus - genetics (99) 99
virus diseases (93) 93
hiv-1 - physiology (84) 84
hiv infections - virology (78) 78
infectious diseases (78) 78
animals (76) 76
human-immunodeficiency-virus (70) 70
molecular sequence data (68) 68
cell line (66) 66
immunodeficiency-virus type-1 (66) 66
hiv-1 (64) 64
immunology (59) 59
infection (59) 59
microbiology (57) 57
hiv-1 - drug effects (52) 52
research (51) 51
env gene products, human immunodeficiency virus - metabolism (49) 49
amino acid sequence (47) 47
hiv-1 - immunology (46) 46
health aspects (43) 43
human immunodeficiency virus--hiv (42) 42
aids (40) 40
hiv infection (39) 39
hiv-1 - metabolism (39) 39
ccr5 (36) 36
receptors, ccr5 - metabolism (36) 36
article (35) 35
mutation (35) 35
female (34) 34
analysis (33) 33
hiv-1 - classification (33) 33
proteins (33) 33
cells, cultured (32) 32
hiv infections - immunology (32) 32
hiv-1 - pathogenicity (32) 32
sequence analysis, dna (32) 32
anti-hiv agents - pharmacology (31) 31
genetic aspects (31) 31
hiv-1 - isolation & purification (31) 31
male (31) 31
env gene products, human immunodeficiency virus - chemistry (30) 30
gene products, env - metabolism (29) 29
gp120 (29) 29
protein (29) 29
receptors, cxcr4 - metabolism (29) 29
physiological aspects (28) 28
research article (28) 28
biochemistry & molecular biology (27) 27
gene products, env - genetics (27) 27
hiv infections - drug therapy (27) 27
human immunodeficiency virus (27) 27
cd4-positive t-lymphocytes - virology (26) 26
envelope glycoprotein (26) 26
hiv fusion inhibitors - pharmacology (26) 26
viral tropism (26) 26
acquired immune deficiency syndrome--aids (25) 25
antiviral agents (25) 25
hiv envelope protein gp120 - genetics (25) 25
virus internalization (25) 25
adult (24) 24
env gene products, human immunodeficiency virus - immunology (24) 24
genetic variation (24) 24
hiv antibodies - immunology (24) 24
multidisciplinary sciences (24) 24
phylogeny (24) 24
protein binding (24) 24
coreceptor usage (23) 23
rna, viral - genetics (23) 23
v3 loop (23) 23
biotechnology & applied microbiology (22) 22
env (22) 22
glycoproteins (22) 22
hela cells (22) 22
in-vivo (22) 22
infectious disease (22) 22
type-1 (22) 22
acquired immune deficiency syndrome (21) 21
expression (21) 21
gene expression (21) 21
mice (21) 21
t-cells (21) 21
base sequence (20) 20
disease progression (20) 20
maraviroc (20) 20
medicine (20) 20
receptor (20) 20
tropism (20) 20
genotype (19) 19
infections (19) 19
models, molecular (19) 19
biology (18) 18
ccr5 receptor antagonists (18) 18
cd4 antigens - metabolism (18) 18
gene products, env - immunology (18) 18
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS pathogens, ISSN 1553-7366, 2013, Volume 9, Issue 9, p. e1003618
A desirable but as yet unachieved property of a human immunodeficiency virus type 1 (HIV-1) vaccine candidate is the ability to induce broadly neutralizing... 
ENVELOPE GLYCOPROTEIN TRIMERS | PROTEIN | VACCINE | GP41 | MICROBIOLOGY | GP120 | CONFORMATIONAL EPITOPE | POTENT | VIROLOGY | IMMUNODEFICIENCY-VIRUS TYPE-1 | BINDING-SITE | MONOCLONAL-ANTIBODIES | PARASITOLOGY | Protein Aggregates | Antibody Specificity | HIV Infections - prevention & control | Molecular Weight | Humans | Antibodies, Neutralizing - metabolism | env Gene Products, Human Immunodeficiency Virus - metabolism | AIDS Vaccines - therapeutic use | HIV Infections - immunology | env Gene Products, Human Immunodeficiency Virus - genetics | Immunoglobulin Fab Fragments - metabolism | env Gene Products, Human Immunodeficiency Virus - antagonists & inhibitors | Protein Stability | Mutant Proteins - antagonists & inhibitors | Peptide Fragments - genetics | env Gene Products, Human Immunodeficiency Virus - chemistry | HIV Antibodies - metabolism | Peptide Fragments - metabolism | Solubility | Antibody Affinity | Mutant Proteins - metabolism | Epitopes | Recombinant Fusion Proteins - chemistry | HIV-1 - immunology | Peptide Fragments - chemistry | Peptide Fragments - antagonists & inhibitors | Mutant Proteins - chemistry | Antibodies, Monoclonal - metabolism | Amino Acid Substitution | Physiological aspects | Genetic aspects | Research | Nucleotide sequencing | HIV (Viruses) | Gene expression | Health aspects | DNA sequencing | Medical research | AIDS | Human immunodeficiency virus | Vaccines | HIV | Acquired immune deficiency syndrome
Journal Article
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 877 - 12
HIV-1 broadly neutralizing antibodies (bNAbs) are being explored as passively administered therapeutic and preventative agents. However, the extensively... 
BISPECIFIC ANTIBODIES | SHIV INFECTION | POTENT NEUTRALIZATION | BROADLY NEUTRALIZING ANTIBODIES | MULTIDISCIPLINARY SCIENCES | IMPROVES PROTECTION | CD4 BINDING | HUMAN MONOCLONAL-ANTIBODIES | HUMAN-IMMUNODEFICIENCY-VIRUS | FITNESS COST | BREADTH | Protein Subunits - immunology | env Gene Products, Human Immunodeficiency Virus - immunology | Antiviral Agents - immunology | Humans | Epitopes - immunology | Antibodies, Neutralizing - immunology | env Gene Products, Human Immunodeficiency Virus - genetics | HIV Antibodies - immunology | Antiviral Agents - chemistry | Antibodies, Neutralizing - therapeutic use | env Gene Products, Human Immunodeficiency Virus - antagonists & inhibitors | Drug Design | Single-Chain Antibodies - therapeutic use | HIV Antibodies - therapeutic use | HIV Antibodies - pharmacology | Antiviral Agents - pharmacology | Single-Chain Antibodies - pharmacology | Antiviral Agents - therapeutic use | HIV-1 - drug effects | Antibodies, Neutralizing - pharmacology | Epitopes - genetics | HIV-1 - genetics | Microscopy, Electron | HIV Antibodies - chemistry | HIV-1 - immunology | Antibodies, Neutralizing - chemistry | HIV Infections - drug therapy | Mutation | Drug Combinations | Single-Chain Antibodies - chemistry | Single-Chain Antibodies - immunology | Antiviral agents | Antibodies | Crosslinking | Glycoproteins | Pharmacology | Epitopes | Chemical compounds | Glycan | CD4 antigen | Human immunodeficiency virus--HIV | Avidity | Binding sites | Neutralization
Journal Article
Journal Article
Current Opinion in HIV and AIDS, ISSN 1746-630X, 05/2017, Volume 12, Issue 3, pp. 294 - 301
Journal Article
Journal of NeuroVirology, ISSN 1355-0284, 8/2017, Volume 23, Issue 4, pp. 587 - 592
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 9/2008, Volume 105, Issue 38, pp. 14365 - 14370
Journal Article